The report predicts the position of the pharmaceutical industry in 2020 and suggests strategies for achieving their goals.
The report found that industry returns on R&D investment reduced by half in 2010 compared to 1990.
Furthermore, the global shift in sales growth to the emerging markets indicates that a further squeeze is coming as margins in these markets are far tighter than in the West.
The report estimates that sales to emerging markets will triple from $154bn in 2010 to $487bn in 2020.